Suppr超能文献

R-(-)-司来吉兰(Selegiline,Movergan)可促进黑质纹状体多巴胺能神经元的活性。

R-(-)-deprenyl (Selegiline, Movergan) facilitates the activity of the nigrostriatal dopaminergic neuron.

作者信息

Knoll J

机构信息

Department of Pharmacology, Semmelweis University of Medicine, Budapest, Hungary.

出版信息

J Neural Transm Suppl. 1987;25:45-66.

PMID:2828537
Abstract

(-)Deprenyl, when administered continuously in small doses (0.25 mg/kg/day), facilitates the activity of the nigrostriatal dopaminergic neuron because of its highly characteristic complex spectrum of pharmacologic activity: it is a highly potent and selective inhibitor of B-type MAO; it inhibits the reuptake of dopamine; it inhibits dopamine autoreceptors; it enhances scavenger function. 1) (-)Deprenyl treatment decreased significantly the activity of the cholinergic interneurons. In a series of experiments the acetylcholine (ACh) content was found to be 0.69 nmole/mg protein in the striatum of untreated rats, whereas a significantly higher amount of ACh (0.86 nmol/mg protein) was found in the rat striatum after two week pretreatment with (-)deprenyl, and the fractional rate constant (kb) of ACh efflux from the cholinergic interneurons of the striatum decreased significantly in the (-)deprenyl-treated group from 9.1 +/- 0.8 to 6.2 +/- 0.55. 2) The (-)deprenyl-induced increase of the dopaminergic tone in the striatum was proved by measurements of the activity of the nigrostriatal dopaminergic neuron. Whereas the striatum of untreated rats contained 52.7 +/- 1.6 nmole/g dopamine (DA) and the turnover rate (TRDA) was found to be 13.7 +/- 1.3 nmole/g/hr, the striatum of rats pretreated with 0.25 mg/kg (-)deprenyl daily for 28 days contained significantly higher amount of DA (81.77 +/- 5.7 nmole) and the turnover rate increased significantly to 24.44 +/- 1.1. Using the Glowinski-Iversen preparation we found that from the striata of untreated rats 200.0 +/- 25.8 pmole/g/min DA was released to KCl stimulation, whereas the amount of DA released to stimulation from the striata of rats pretreated with (-)deprenyl for 3 weeks increased significantly to 1452.2 +/- 183.1 pmole/g/min. 3) (-)Deprenyl inhibits the uptake of dopamine into the nigrostriatal dopaminergic neuron. In a new series of experiments we found that 420 +/- 21 pmole/g protein 3H-DA was taken up within 5 minutes in the striatum slices of untreated rats. Pretreatment of the rats with 0.25 mg/kg (-)deprenyl daily for two weeks decreased significantly the uptake of DA to 284 +/- 28 pmole/mg. 4) In a new series of experiments we found that the striata of untreated rats emitted 404.2 +/- 36.2 pmole/g/min ACh to ouabain stimulation but the striata dissected from rats pretreated with 6-hydroxy-dopamine (6-OHDA) released 811.4 +/- 49.2 pmol/g/min (p less than or equal to 0.001).

摘要

(-)司来吉兰连续小剂量给药(0.25毫克/千克/天)时,因其具有高度独特的复杂药理活性谱,可促进黑质纹状体多巴胺能神经元的活性:它是一种高效且选择性的B型单胺氧化酶抑制剂;它抑制多巴胺的再摄取;它抑制多巴胺自身受体;它增强清除功能。1)(-)司来吉兰治疗显著降低了胆碱能中间神经元的活性。在一系列实验中,未处理大鼠纹状体中的乙酰胆碱(ACh)含量为0.69纳摩尔/毫克蛋白质,而在用(-)司来吉兰预处理两周后的大鼠纹状体中,发现ACh含量显著更高(0.86纳摩尔/毫克蛋白质),并且在(-)司来吉兰处理组中,纹状体胆碱能中间神经元的ACh流出分数速率常数(kb)从9.1±0.8显著降低至6.2±0.55。2)通过测量黑质纹状体多巴胺能神经元的活性,证实了(-)司来吉兰诱导的纹状体多巴胺能张力增加。未处理大鼠的纹状体中含有52.7±1.6纳摩尔/克多巴胺(DA),周转率(TRDA)为13.7±1.3纳摩尔/克/小时,而每天用0.25毫克/千克(-)司来吉兰预处理28天的大鼠纹状体中,DA含量显著更高(81.77±5.7纳摩尔),周转率显著增加至24.44±1.1。使用格洛温斯基 - 艾弗森标本,我们发现未处理大鼠的纹状体在氯化钾刺激下释放200.0±25.8皮摩尔/克/分钟的DA,而用(-)司来吉兰预处理3周的大鼠纹状体在刺激下释放的DA量显著增加至1452.2±183.1皮摩尔/克/分钟。3)(-)司来吉兰抑制多巴胺进入黑质纹状体多巴胺能神经元的摄取。在一系列新实验中,我们发现未处理大鼠纹状体切片在5分钟内摄取420±21皮摩尔/克蛋白质的3H - DA。大鼠每天用0.25毫克/千克(-)司来吉兰预处理两周后,DA摄取量显著降低至284±28皮摩尔/毫克。4)在一系列新实验中,我们发现未处理大鼠的纹状体在哇巴因刺激下释放404.2±36.2皮摩尔/克/分钟的ACh,但从用6 - 羟基多巴胺(6 - OHDA)预处理的大鼠中分离出的纹状体释放811.4±49.2皮摩尔/克/分钟(p≤0.001)。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验